LEAP-012 TRIAL IN PROGRESS: PEMBROLIZUMAB, LENVATINIB, AND TRANSARTERIAL CHEMOEMBOLIZATION COMBINATION THERAPY FOR INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA NOT AMENABLE TO CURATIVE TREATMENT

被引：0
|
作者：
Vogel, Arndt [1 ]
Llovet, Josep M. [2 ]
El-Khoueiry, Anthony B. [3 ]
Madoff, David C. [4 ,5 ]
Finn, Richard [6 ]
Ogasawara, Sadahisa [7 ]
Ren, Zhenggang [8 ]
Mody, Kalgi [9 ]
Li, Jerry J. [10 ]
Siegel, Abby B. [10 ]
Dubrovsky, Leonid [10 ]
Kudo, Masatoshi [11 ]
机构：
[1] Hannover Med Sch, Hannover, Germany
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA
[4] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
[5] Yale New Haven Hlth, Smilow Canc Hosp, New Haven, CT USA
[6] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[7] Chiba Univ, Grad Sch Med, Chiba, Japan
[8] Fudan Univ, Zhongshan Hosp, Dept Hepat Oncol, Shanghai, Peoples R China
[9] Eisai Inc, Woodcliff Lake, NJ USA
[10] Merck & Co Inc, Kenilworth, NJ USA
[11] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Higashiosaka, Osaka, Japan
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1156
引用
收藏
页码：697A / 698A
页数：2
相关论文
共 50 条
  • [21] Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Motoyama, Tenyu
    Suzuki, Eiichiro
    Tawada, Akinobu
    Kanai, Fumihiko
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    ONCOLOGY, 2014, 87 (06) : 330 - 341
  • [22] Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?
    Chen, Shuling
    Peng, Zhenwei
    Zhang, Yaojun
    Chen, Minshan
    Li, Jiaping
    Guo, Rongping
    Li, Jiali
    Li, Bin
    Mei, Jie
    Feng, Shiting
    Kuang, Ming
    RADIOLOGY, 2021, 298 (03) : 680 - 692
  • [23] A multicenter cohort study on transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma: Reconsidering combination-therapy trial design.
    Zhao, Yan
    Li, Hailiang
    Bai, Wei
    Liu, Jueshi
    Lv, Weifu
    Guan, Sheng
    Qin, Xiao
    Wang, Wenhui
    Ren, Weixin
    Mu, Wei
    Guo, Weidong
    Gu, Shanzhi
    Ma, Yilong
    Yin, Zhanxin
    Guo, Wengang
    Wang, Yongji
    Xia, Jielai
    Duran, Rafael
    Fan, Daiming
    Han, Guohong
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial Protocol
    Nicholas Fidelman
    CardioVascular and Interventional Radiology, 2022, 45 : 413 - 414
  • [25] Transarterial- chemoembolization remains an effective therapy for intermediate-stage hepatocellular carcinoma with preserved liver function
    Saito, Natsuhiko
    Tanaka, Toshihiro
    Nishiohuku, Hideyuki
    Sato, Takeshi
    Masada, Tetsuya
    Matsumoto, Takeshi
    Anai, Hiroshi
    Sakaguchi, Hiroshi
    Sueyoshi, Satoru
    Marugami, Nagaaki
    Kichikawa, Kimihiko
    HEPATOLOGY RESEARCH, 2020, 50 (10) : 1176 - 1185
  • [26] A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial Protocol
    Fidelman, Nicholas
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2022, 45 (04) : 413 - 414
  • [27] Role of curative treatment in patients with intermediate-stage hepatocellular carcinoma
    Yuichi Sugino
    Koichiro Yamakado
    Takashi Yamanaka
    Masashi Fujimori
    Atsuhiro Nakatsuka
    Haruyuki Takaki
    Yoshiyuki Takei
    Hajime Sakuma
    Shuji Isaji
    Japanese Journal of Radiology, 2017, 35 : 254 - 261
  • [28] Role of curative treatment in patients with intermediate-stage hepatocellular carcinoma
    Sugino, Yuichi
    Yamakado, Koichiro
    Yamanaka, Takashi
    Fujimori, Masashi
    Nakatsuka, Atsuhiro
    Takaki, Haruyuki
    Takei, Yoshiyuki
    Sakuma, Hajime
    Isaji, Shuji
    JAPANESE JOURNAL OF RADIOLOGY, 2017, 35 (05) : 254 - 261
  • [29] Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma
    Peng, Zhenwei
    Chen, Shuling
    Xiao, Han
    Wang, Yu
    Li, Jiaping
    Mei, Jie
    Chen, Zebin
    Zhou, Qian
    Feng, Shiting
    Chen, Minshan
    Qian, Guojun
    Peng, Sui
    Kuang, Ming
    RADIOLOGY, 2019, 292 (01) : 237 - 247
  • [30] Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization
    Ashour, Reham
    Rewisha, Eman
    Rady, Mohamed A. K. L.
    Elkhadry, Sally Waheed
    Abdelhalim, Heba
    Atef, Mohamed
    BMC CANCER, 2024, 24 (01)
12345